Efficacy and Safety of Intralesional 5-Fluorouracil and Triamcinolone Acetonide in Keloids and Hypertrophic Scars

CompletedOBSERVATIONAL
Enrollment

41

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

September 1, 2021

Study Completion Date

September 1, 2021

Conditions
Keloids
Interventions
DRUG

Intralesional Triamcinolone 5 mg/ml

Solution containing 5 mg TAC was injected intralesionally, every week for 6 weeks or until the scar flattened, whichever occurred earlier. Not more than 2 ml of the solution was injected per session, using 27G needle pre-mounted on an insulin syringe.

DRUG

Intralesional 5-fluorouracil

Solution containing 45 mg 5-FU was injected intralesionally, every week for 6 weeks or until the scar flattened, whichever occurred earlier. Not more than 2 ml of the solution was injected per session, using 27G needle pre-mounted on an insulin syringe.

Trial Locations (1)

Unknown

Maharajgunj Medical Campus, Institute of Medicine, Kathmandu

All Listed Sponsors
lead

Maharajgunj Medical Campus

OTHER

NCT07034482 - Efficacy and Safety of Intralesional 5-Fluorouracil and Triamcinolone Acetonide in Keloids and Hypertrophic Scars | Biotech Hunter | Biotech Hunter